65,437 trials
Central Neuropathic Pain · Allodynia · Spinal Cord Injury
Primary: Percent Change in Peak Pain Intensity — -2.5; -7.9; -11.2; -19.2 percentage change from baseline — p=0.0322
Dyslipidemia
Primary: Percent Change From Baseline to 12 Weeks Endpoint in High Density Lipoprotein Cholesterol (HDL-C) With LY2484595 in Combination With Atorvastatin and Atorvastatin…
Breast Cancer
Primary: Change From Baseline in Functional Assessment of Cancer Therapy-Breast Cancer (FACT-B) Score at Cycle 2 — 98.3; 102.21; 5.83; -2.48 units on a scale
DS Stage I Plasma Cell Myeloma · DS Stage II Plasma Cell Myeloma · DS Stage III Plasma Cell Myeloma
Primary: Episodes of Grade 3-4 Non Infectious, Non-dermatological or Non-neurological Toxicities, Episodes of Any Infections, Grade 3-4 Dermatological or Episodes of Grade 2-3…
Uncontrolled Asthma
Primary: Annualised Asthma Exacerbation Rate (AAER) up to Week 52 — 0.80; 0.95; 0.87; 0.77 Events/year — p=0.4656
Carcinoma of the Appendix · Primary Peritoneal Cavity Cancer
Primary: The Difference in the Number of Grade 3 or 4 Hematologic Toxicities (Leukopenia, Thrombocytopenia, and Neutropenia) Between the Mitomycin C and Oxaliplatin Treatments…
Cerebrovascular Accident · Deglutition Disorders
Primary: Isometric Lingual Pressure — 49 kPa
Psoriasis
Primary: Percentage of Participants With Physician's Global Assessment (PGA) Ratings of Good or Better (FT) — 68.0 percentage of participants
Prostate Cancer
Primary: Uptake and Retention of Eovist in Prostate Cancers — 2.01; 1.857; 2.52; 2.212 contrast enhancement ratio (CER) — p=0.0008
MRSA
Primary: Number of Participants With Recurrent Methicillin-resistant Staphylococcus Aureus (MRSA) Colonization — 2; 3 Participants
Iron, Blood Level Abnormal
Primary: Non-transferrin-bound Iron Level (AUC) — 0.5588; 2.839; 3.684; 5.272 microMole*hr/L
Rheumatoid Arthritis
Primary: Percentage of Subjects Meeting the American College of Rheumatology 20 % Response Criteria (ACR20) at Week 24 — 23.9; 54.8 percentage of participants — p=<0.001
Mucinous Pancreatic Cysts
Primary: Number of Participants With the Changing in Cyst Volume — 6; 12; 5; 4 Participants
Schizophrenia
Primary: Change From Baseline in Positive and Negative Syndrome Scale (PANSS) Total Score at Week 4 — 98.1; 97.7; 97.4; 97.2 units on a scale — p=0.2053
Osteoarthritis of the Knee
Primary: Change From Baseline to Week 12 in the Weekly Mean of the Average Daily (24-hr) Pain Intensity Scores for 32 mg FX006 Versus Placebo — -3.08; -2.50 units on a scale…